Serum Levels of Annexin A2 as a Candidate Biomarker for Hepatic Fibrosis in Patients With Chronic Hepatitis B


Kolgelier S., Demir N. A. , İNKAYA A. Ç. , Sumer S., OZCIMEN S., Demir L. S. , ...More

HEPATITIS MONTHLY, vol.15, no.10, 2015 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 15 Issue: 10
  • Publication Date: 2015
  • Doi Number: 10.5812/hepatmon.30655
  • Journal Name: HEPATITIS MONTHLY
  • Journal Indexes: Science Citation Index Expanded, Scopus

Abstract

Background: Hepatologists have studied serologic markers of liver injury for decades. Annexins are a prominent group of such markers and annexin A2 (AnxA2) is one of the best characterized annexins. AnxA2 inhibits HBV polymerase among other functions. Its expression is up-regulated in regenerative hepatocytes.